Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1988 1
1990 1
1992 5
1993 1
1994 2
1995 4
1996 3
1997 4
1998 9
1999 1
2000 9
2001 9
2002 9
2003 10
2004 17
2005 16
2006 19
2007 14
2008 14
2009 27
2010 42
2011 44
2012 37
2013 48
2014 51
2015 72
2016 76
2017 83
2018 87
2019 137
2020 123
2021 131
2022 136
2023 163
2024 187
2025 186
2026 180

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,775 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean tra tt[au] (6 results)?
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.
Weber JS, Carlino MS, Khattak A, Meniawy T, Ansstas G, Taylor MH, Kim KB, McKean M, Long GV, Sullivan RJ, Faries M, Tran TT, Cowey CL, Pecora A, Shaheen M, Segar J, Medina T, Atkinson V, Gibney GT, Luke JJ, Thomas S, Buchbinder EI, Healy JA, Huang M, Morrissey M, Feldman I, Sehgal V, Robert-Tissot C, Hou P, Zhu L, Brown M, Aanur P, Meehan RS, Zaks T. Weber JS, et al. Among authors: tran tt. Lancet. 2024 Feb 17;403(10427):632-644. doi: 10.1016/S0140-6736(23)02268-7. Epub 2024 Jan 18. Lancet. 2024. PMID: 38246194 Clinical Trial.
Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study.
Shields RK, Abbo LM, Ackley R, Aitken SL, Albrecht B, Babiker A, Burgoon R, Cifuentes R, Claeys KC, Curry BN, DeSear KE, Gallagher JC, Golnabi EY, Gross AE, Hand J, Heil EL, Hornback KM, Kaye KS, Khuu TV, Klatt ME, Kline EG, Kubat RC, Kufel WD, Lee JH, Lepak AJ, Lim A, Ludwig JM, Macdougall C, Majumdar A, Mathers AJ, McCreary EK, Miller WR, Monogue ML, Moore WJ, Olson S, Oxer J, Pearson JC, Pham C, Pinargote P, Polk C, Satlin MJ, Satola SW, Shah S, Tamma PD, Tran TT, van Duin D, VanNatta M, Vega A, Venugopalan V, Veve MP, Wangchinda W, Witt LS, Wu JY, Pogue JM; PRECEDENT Network. Shields RK, et al. Among authors: tran tt. Lancet Infect Dis. 2025 May;25(5):574-584. doi: 10.1016/S1473-3099(24)00648-0. Epub 2024 Dec 16. Lancet Infect Dis. 2025. PMID: 39701120
Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase IIb KEYNOTE-942 Study.
Khattak A, Carlino MS, Meniawy T, Ansstas G, Taylor MH, Kim KB, McKean M, Long GV, Sullivan RJ, Faries M, Tran TT, Cowey CL, Pecora A, Medina T, Atkinson V, Krepler C, Jemielita T, Mao H, Chow J, Ojalvo LS, Mehnert JM; KEYNOTE-942 Investigators. Khattak A, et al. Among authors: tran tt. J Clin Oncol. 2026 Sep 10;44(26):2482-2489. doi: 10.1200/JCO-26-00835. Epub 2026 Jun 1. J Clin Oncol. 2026. PMID: 42223134 Clinical Trial.
Targeting an essential viral oncoprotein with an IL-7-enhanced mRNA vaccine induces durable immunity to Merkel cell carcinoma.
Frey A, Clulo K, Fei Y, Dumit TC, Scallo F, Allen JW, Chang E, Perry CJ, Wirth LV, Jacobs D, Braun DA, Bosenberg MW, Tran TT, Clune J, Kluger HM, Olino K, Ishizuka JJ. Frey A, et al. Among authors: tran tt. Cell Rep. 2025 Oct 28;44(10):116359. doi: 10.1016/j.celrep.2025.116359. Epub 2025 Oct 1. Cell Rep. 2025. PMID: 41042672 Free PMC article.
TCR-engineered T cells targeting a shared β-catenin mutation eradicate solid tumors.
Eggebø MS, Heinzelbecker J, Palashati H, Chandler N, Tran TT, Li Y, Yang W, Laos M, Blaas I, Rustad EH, Bollineni RC, Delic-Sarac M, Lund-Johansen F, Nielsen MM, Olweus J. Eggebø MS, et al. Among authors: tran tt. Nat Immunol. 2025 Oct;26(10):1726-1736. doi: 10.1038/s41590-025-02252-1. Epub 2025 Aug 27. Nat Immunol. 2025. PMID: 40866620 Free PMC article.
Vascular mimicry as a facilitator of melanoma brain metastasis.
Provance OK, Oria VO, Tran TT, Caulfield JI, Zito CR, Aguirre-Ducler A, Schalper KA, Kluger HM, Jilaveanu LB. Provance OK, et al. Among authors: tran tt. Cell Mol Life Sci. 2024 Apr 18;81(1):188. doi: 10.1007/s00018-024-05217-z. Cell Mol Life Sci. 2024. PMID: 38635031 Free PMC article.
Improving immunotherapy responses by dual inhibition of macrophage migration inhibitory factor and PD-1.
Tran TT, Sánchez-Zuno GA, Osmani L, Caulfield J, Valdez CN, Piecychna M, Leng L, Armstrong ME, Donnelly SC, Bifulco CB, Clister T, Kulkarni RP, Zhang L, Sznol M, Jilaveanu L, Kluger HM, Kang I, Bucala R. Tran TT, et al. JCI Insight. 2025 Oct 22;10(20):e191539. doi: 10.1172/jci.insight.191539. eCollection 2025 Oct 22. JCI Insight. 2025. PMID: 41122966 Free PMC article.
1,775 results